UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

Annals of oncology, 2017-02, Vol.28 (2), p.270-277

2017

Volltextzugriff (PDF)

A retrospective cohort study of intra-corporeal versus extra-corporeal anastomosis for right hemicolectomy with cost-effectiveness analysis

Techniques in coloproctology, 2024-06, Vol.28 (1), p.66

2024

Volltextzugriff (PDF)

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

European journal of cancer (1990), 2011-03, Vol.47 (5), p.656-666

2011

Volltextzugriff (PDF)

Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers

Annals of oncology, 2012-04, Vol.23 (4), p.1010-1016

2012

Volltextzugriff (PDF)

A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma

Annals of oncology, 2012-04, Vol.23 (4), p.997-1005

2012

Volltextzugriff (PDF)

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer

Annals of oncology, 2012-01, Vol.23 (1), p.72-77

2012

Volltextzugriff (PDF)

Functions of TAp63 and p53 in restraining the development of metastatic cancer

Oncogene, 2014-06, Vol.33 (25), p.3325-3333

2014

Volltextzugriff (PDF)

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer : a randomised comparison

British journal of cancer, 2005-08, Vol.93 (3), p.279-286

2005

Volltextzugriff (PDF)

Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors

Annals of oncology, 2010-02, Vol.21 (2), p.382-388

2010

Volltextzugriff (PDF)

Graves Ophthalmopathy: The Bony Orbit in Optic Neuropathy, Its Apical Angular Capacity, and Impact on Prediction of Risk

American journal of neuroradiology : AJNR, 2009-03, Vol.30 (3), p.597-602

2009

Volltextzugriff (PDF)

Associations between cardiovascular disease and its risk factors with hearing loss—A cross‐sectional analysis

Clinical otolaryngology, 2018-02, Vol.43 (1), p.172-181

2018

Volltextzugriff (PDF)

Travel warning with capecitabine

Annals of oncology, 2009-07, Vol.20 (7), p.1281-1281

2009

Volltextzugriff (PDF)

Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma

Annals of oncology, 2011-03, Vol.22 (3), p.718-722

2011

Volltextzugriff (PDF)

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer

Annals of oncology, 2009-07, Vol.20 (7), p.1249-1256

2009

Volltextzugriff (PDF)

A Systematic Scoping Review on Pedagogical Strategies of Interprofessional Communication for Physicians in Emergency Medicine

Journal of Medical Education and Curricular Development, 2021-01, Vol.8, p.23821205211041794-23821205211041794

2021

Volltextzugriff (PDF)

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)

Investigational new drugs, 2015-08, Vol.33 (4), p.985-991

2015

Volltextzugriff (PDF)

139PD Lifetime incidence of brain metastases (BM) in EGFR-mutant (M+) lung cancer treated with first-line EGFR TKIs

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S117-S117

2016

Volltextzugriff (PDF)

A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer

Annals of oncology, 2010-02, Vol.21 (2), p.217-222

2010

Volltextzugriff (PDF)

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

Annals of oncology, 2002, Vol.13 (1), p.150-156

2002

Volltextzugriff (PDF)

140PD LUX-Lung 7: A Phase IIb, global, randomised, open-label trial of afatinib vs gefitinib as first-line treatment for patients (pts) with advanced non-small cell lung cancer (NSCLC) harbouring activating EGFR mutations

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S117-S118

2016

Volltextzugriff (PDF)

Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas

Acta radiologica (1987), 2011-05, Vol.52 (4), p.463-466

2011

Volltextzugriff (PDF)

Yttrium-90 internal pair production imaging using first generation PET/CT provides high-resolution images for qualitative diagnostic purposes

British journal of radiology, 2012-07, Vol.85 (1015), p.1018-1019

2012

Volltextzugriff (PDF)

Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma

Annals of oncology, 1999-02, Vol.10 (2), p.235-237

1999

Volltextzugriff (PDF)

Design of a prognostic index score for metastatic nasopharyngeal carcinoma

European journal of cancer (1990), 2003-07, Vol.39 (11), p.1535-1541

2003

Volltextzugriff (PDF)

1 – 25 von 9.136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.925)
Mit Volltextzugriff
(7.755)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(3.958)
EZB Electronic Journals Library
(3.885)
Ingenta
(3.573)
Journals@Ovid Full Text
(2.992)
NUS Single-Journal Subscriptions
(1.791)
Elsevier ScienceDirect Journals Complete
(1.673)
Wiley
(1.237)
IngentaConnect Journals
(1.088)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.071)
Wiley Online Library
(910)
SpringerLink
(764)
IEEE Electronic Library Online
(467)
Oxford journals
(463)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(447)
Springer Nature - Connect here FIRST to enable access
(364)
APS_美国物理学会期刊
(303)
Oxford Journals 2020 Medicine
(299)
Ebook Central Perpetual and DDA
(277)
eBooks on EBSCOhost
(267)
SpringerLink Series
(241)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(120)
Annals Of The Academy Of Medicine, Singapore
(115)
Singapore Medical Journal
(102)
Journal Of Clinical Oncology
(92)
Physical Review. D
(90)
Physical Review Letters
(73)
Cancer Research
(72)
Pediatrics
(66)
The New England Journal Of Medicine
(57)
European Heart Journal
(54)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

A retrospective cohort study of intra-corporeal versus extra-corporeal anastomosis for right hemicolectomy with cost-effectiveness analysis

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers

A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer

Functions of TAp63 and p53 in restraining the development of metastatic cancer

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer : a randomised comparison

Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors

Graves Ophthalmopathy: The Bony Orbit in Optic Neuropathy, Its Apical Angular Capacity, and Impact on Prediction of Risk

Associations between cardiovascular disease and its risk factors with hearing loss—A cross‐sectional analysis

Travel warning with capecitabine

Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer

A Systematic Scoping Review on Pedagogical Strategies of Interprofessional Communication for Physicians in Emergency Medicine

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)

139PD Lifetime incidence of brain metastases (BM) in EGFR-mutant (M+) lung cancer treated with first-line EGFR TKIs

A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

140PD LUX-Lung 7: A Phase IIb, global, randomised, open-label trial of afatinib vs gefitinib as first-line treatment for patients (pts) with advanced non-small cell lung cancer (NSCLC) harbouring activating EGFR mutations

Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas

Yttrium-90 internal pair production imaging using first generation PET/CT provides high-resolution images for qualitative diagnostic purposes

Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma

Design of a prognostic index score for metastatic nasopharyngeal carcinoma

Suchergebnisse filtern